About
Isolere Bio develops chromatography-free reagents based on affinity and phase separation technology to improve the purification, purity, and yield of advanced therapeutics such as viral vectors used in gene therapy.
Explore Isolere Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.